scispace - formally typeset
Open AccessJournal ArticleDOI

Diagnosis of leishmaniasis

TLDR
The current state of the diagnostic tools for leishmaniasis are reviewed, especially the serological test, which is required for accurate diagnosis in immunocompromised patients such as those infected with HIV.
Abstract
Leishmaniasis is a clinically heterogeneous syndrome caused by intracellular protozoan parasites of the genus Leishmania. The clinical spectrum of leishmaniasis encompasses subclinical ( not apparent), localized (skin lesion), and disseminated (cutaneous, mucocutaneous, and visceral) infection. This spectrum of manifestations depends on the immune status of the host, on the parasite, and on immunoinflammatory responses. Visceral leishmaniasis causes high morbidity and mortality in the developing world. Reliable laboratory methods become mandatory for accurate diagnosis, especially in immunocompromised patients such as those infected with HIV. In this article, we review the current state of the diagnostic tools for leishmaniasis, especially the serological test.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Recent updates and perspectives on leishmaniasis

TL;DR: The diagnostic, chemotherapeutic, and immunizing strategies to control leishmaniasis are highlighted, though no human vaccine is commercially available currently owing to the complexity of the cellular immune response to this parasite.
Journal ArticleDOI

Major Parasitic Zoonoses Associated with Dogs and Cats in Europe

TL;DR: The main parasitic zoonoses in Europe related to dogs and cats are described, with particular emphasis on their current epidemiology, with an emphasis on parasite life cycle, transmission, pathogenicity, prevention and identification of knowledge gaps.
Journal ArticleDOI

Identification of Proteins in Promastigote and Amastigote-like Leishmania Using an Immunoproteomic Approach

TL;DR: A significant contribution not only in identifying stage-specific L. infantum molecules, but also in revealing the expression of a large number of hypothetical proteins that constitute a significant source of information for the improvement of diagnostic tools and/or vaccine development to VL.
Journal Article

Laboratory diagnosis of human visceral leishmaniasis.

TL;DR: Quantitative polymerase chain reaction (qPCR) has been shown to be superior than conventional PCR for the differentiation between active VL and asymptomatic infections, such as for the detection of VL-HIV coinfection.
References
More filters
Journal ArticleDOI

Leishmaniasis Worldwide and Global Estimates of Its Incidence

TL;DR: Visceral and cutaneous leishmaniasis incidence ranges were estimated by country and epidemiological region based on reported incidence, underreporting rates if available, and the judgment of national and international experts.
Journal ArticleDOI

Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?

TL;DR: Millefosine, paromomycin and liposomal amphotericin B are gradually replacing pentavalent antimonials and conventional amphoteric in B as the preferred treatments in some regions, but in other areas these drugs are still being evaluated in both mono- and combination therapies.
Journal ArticleDOI

The Relationship between Leishmaniasis and AIDS: the Second 10 Years

TL;DR: Based on the previous experience of 20 years of coinfection in Europe, this review focuses on the management of Leishmania-HIV-coinfected patients in low-income countries where leishmaniasis is endemic.
Journal ArticleDOI

Leishmania and human immunodeficiency virus coinfection: the first 10 years.

TL;DR: Over 850 Leishmania-human immunodeficiency virus (HIV) coinfection cases have been recorded, the majority in Europe, where 7 to 17% of HIV-positive individuals with fever have amastigotes, suggesting that Leishmanniasis-infected individuals without symptoms will express symptoms of leishmaniasis if they become immunosuppressed.
Journal ArticleDOI

Molecular characterization of a kinesin-related antigen of Leishmania chagasi that detects specific antibody in African and American visceral leishmaniasis.

TL;DR: The cloning of a Leishmania chagasi antigen gene and an evaluation of leishmaniasis patient antibody responses to the recombinant protein, rK39, show that rK 39 may replace crude parasite antigens as a basis for serological diagnosis of visceral leish maniasis.
Related Papers (5)